Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FCMTK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,725
Award facts
- Contract value 100% obligated
- $24,724.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $24,724.65 for Entyvio 300 mg vials. The contract was awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's contract portfolio with DLA demonstrates expertise in distributing specialized medications across therapeutic categories, from oncology treatments to vaccines and specialty injections. This particular delivery order for Entyvio, a specialty biologic medication, reflects the contractor's role in supporting critical pharmaceutical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FCMTK?
SPE2DB25FCMTK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FCMTK worth?
The government has obligated $24,725 on SPE2DB25FCMTK.
Is contract SPE2DB25FCMTK an order under another contract?
Yes. SPE2DB25FCMTK is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMTK competed?
The extent of competition for SPE2DB25FCMTK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award